Allogene Therapeutics: Board
CommitteesIndependence
Franz Humer, Ph.D.Lead independent directorCompensation (Chair), International and Business Development Oversight (Chair)Independent7 yrNot disclosed
John DeYoungDirectorCompensation, International and Business Development OversightIndependent7 yrNot disclosed
Owen Witte, M.D.DirectorNominating and Corporate Governance (Chair), Research and Development (Chair)Independent7 yrNot disclosed
3 seats

The board of the latest proxy statement.